|
2025
|
P/S
|
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cardiovascular, renal, hepatologi... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of cardiovascular, metabolic, and r... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of diseases and disorders of the ren... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, re... |
|
|
Invention
|
Arginase inhibitors and methods of use thereof.
Disclosed are compounds of formula (Ib) or (Vc),... |
|
|
Invention
|
Compositions and methods for delivering a macromolecule to a cell 2. Compounds and methods are pr... |
|
|
Invention
|
Salts and polymorphs of cx3cr1 modulators. The present disclosure provides meglumine salts of CX3... |
|
|
Invention
|
Thio-substituted 1,3,5-triazine cx3cr1 modulators. The present disclosure provides thio-substitut... |
|
|
Invention
|
Small molecule cx3cr1 modulators. 311, pharmaceutical compositions thereof and uses thereof for t... |
|
|
Invention
|
Oral formulation of a therapeutic compound.
The present invention provides a pharmaceutical tabl... |
|
|
Invention
|
Egfr tkis for use in the treatment of non-small lung cancer.
The specification relates to epider... |
|
|
Invention
|
Treatment of limited-stage small-cell lung cancer with pd-l1 inhibitors. The disclosure relates t... |
|
|
Invention
|
Dose-dependent administration of inhibitor of pnpla3 expression. The present disclosure provides ... |
|
|
Invention
|
Crystalline form of (s)-n-ethyl-3-((9-ethyl-2-(((2r,3s)-2-hydroxypentan-3-yl)amino)-9h-purin-6-yl... |
|
|
Invention
|
Pcsk9 inhibitors and methods of use thereof. A compound with the Formula (I): A-B-C (I) or a phar... |
|
|
Invention
|
Methods of delaying pain progression and treating prostate cancer.
This disclosure relates to me... |
|
|
Invention
|
Processes and compounds for the preparation of topoisomerase i inhibitor linker-payloads. This sp... |
|
|
Invention
|
Azd1390, or a pharmaceutically acceptable salt thereof, in combination with radiation for use in ... |
|
|
Invention
|
Process and intermediates for the production of a jak1 inhibitor. A process and intermediates for... |
|
|
Invention
|
Treatment of chronic kidney disease. The disclosure relates to methods and compositions for the t... |
|
|
Invention
|
Triple combination therapy for copd. The present disclosure provides a method of treating chronic... |
|
|
Invention
|
Therapeutic combination of an akt inhibitor, a bcl-2 inhibitor, and an anti-cd20 antibody. Therap... |
|
|
Invention
|
Inhibitors of myeloperoxidase. Crystalline 2-thioxo-1-((2-((2R,4S)-4-(trifluoromethyl)piperidin-2... |
|
|
Invention
|
Compositions and methods for treatment of huntington's disease. The present disclosure relates to... |
|
|
Invention
|
Double-stranded rnai agents and compositions for reducing expression of angiopoietin-like 3 (angp... |
|
|
Invention
|
Engineered cells expressing modified hla-e polypeptide. Provided are hypoimmunogenic cells and me... |
|
|
Invention
|
Pharmaceutical compositions comprising azd0780. A pharmaceutical composition comprising: (a) from... |
|
|
Invention
|
Azd-0780 in combination with a statin for use in lowering ldl-c levels and treating cardiovacular... |
|
|
Invention
|
Cd8-binding cytokine engagers and methods of use thereof. The disclosure provides a cytokine enga... |
|
|
Invention
|
Cytokine engagers and uses thereof.
The disclosure provides a cytokine engager comprising an ant... |
|
|
Invention
|
Combination of zibotentan and dapagliflozin for use for the treatment of hypertension. Methods fo... |
|
|
Invention
|
Compositions of thymic stromal lymphopoietin (tslp) binding fragments and methods of use thereof.... |
|
|
Invention
|
Pharmaceutical compositions comprising azd5305. A pharmaceutical composition comprising: (a) from... |
|
|
Invention
|
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiecta... |
|
|
Invention
|
Piperidine derivatives as inhibitors of nicotinamide n-methyl transferase. There are disclosed ce... |
|
|
Invention
|
Benzylpiperidine derivatives as trp4 antagonists for the treatment of inflammatory diseases. The ... |
|
2024
|
Invention
|
Arginase inhibitors and methods of use thereof.
Disclosed are compounds of formula (Ia) or a pha... |
|
2023
|
Invention
|
Anti-ctla antibody compositions and related methods.
The present disclosure provides composition... |
|
|
Invention
|
Methods for unified concentration and buffer exchange.
Provided herein are methods of purifying ... |
|
|
Invention
|
Solid forms of heterocyclylamides as irak4 inhibitors.
The present specification relates to nove... |
|
|
Invention
|
Predicting disease progression in portal hypertension using machine learning.
An example embodim... |
|
|
Invention
|
Predicting albuminuria using machine learning.
An example embodiment may involve obtaining, by a... |
|
|
Invention
|
Condensed bicyclic heteroaromatic compounds and their use in the treatment of cancer.
The specif... |
|
|
Invention
|
Improved process for the manufacture of osimertinib.
This specification relates an improved proc... |
|
|
Invention
|
Combination therapy for treating cancer.
The present disclosure includes methods, pharmaceutical... |
|
|
Invention
|
Method for predicting patient response to immunotherapy.
Methods for treating a patient having a... |
|
2022
|
Invention
|
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators.
There are disclosed certain... |
|
|
Invention
|
Treatment of lupus.
The disclosure relates to methods and compositions for the treatment of syst... |
|
2021
|
Invention
|
Oligonucleotides conjugated to fatty acids.
Provided are lipid conjugated oligonucleotides that ... |
|
|
Invention
|
Methods of determining pten copy number.
Methods of determining PTEN copy number are described. ... |
